1
|
Harcken C, Kuzmich D, Cook B, Mao C, Disalvo D, Razavi H, Swinamer A, Liu P, Zhang Q, Kukulka A, Skow D, Patel M, Patel M, Fletcher K, Sherry T, Joseph D, Smith D, Canfield M, Souza D, Bogdanffy M, Berg K, Brown M. Identification of novel azaindazole CCR1 antagonist clinical candidates. Bioorg Med Chem Lett 2019; 29:441-448. [PMID: 30595446 DOI: 10.1016/j.bmcl.2018.12.024] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2018] [Revised: 12/08/2018] [Accepted: 12/12/2018] [Indexed: 11/27/2022]
Abstract
Exploring various cyclization strategies, using a submicromolar pyrazole HTS screening hit 6 as a starting point, a novel indazole based CCR1 antagonist core was discovered. This report presents the design and SAR of CCR1 indazole and azaindazole antagonists leading to the identification of three development compounds, including 19e that was advanced to early clinical trials.
Collapse
Affiliation(s)
- Christian Harcken
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA.
| | - Daniel Kuzmich
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Brain Cook
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Can Mao
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Darren Disalvo
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Hossein Razavi
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Alan Swinamer
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Pingrong Liu
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Qiang Zhang
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Alison Kukulka
- Compound Profiling Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Donna Skow
- Compound Profiling Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Mita Patel
- Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Monica Patel
- Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Kimberly Fletcher
- Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Tara Sherry
- Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - David Joseph
- Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Dustin Smith
- Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Melissa Canfield
- Immunology & Respiratory Disease Research Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Donald Souza
- Immunology & Respiratory Disease Research Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Matthew Bogdanffy
- Non-Clinical Drug Safety Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Karen Berg
- Immunology & Respiratory Disease Research Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Maryanne Brown
- Immunology & Respiratory Disease Research Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| |
Collapse
|
2
|
Harcken C, Sarko C, Mao C, Lord J, Raudenbush B, Razavi H, Liu P, Swinamer A, Disalvo D, Lee T, Lin S, Kukulka A, Grbic H, Patel M, Patel M, Fletcher K, Joseph D, White D, Amodeo L, Berg K, Brown M, Thomson DS. Discovery and optimization of pyrazole amides as antagonists of CCR1. Bioorg Med Chem Lett 2019; 29:435-440. [PMID: 30455146 DOI: 10.1016/j.bmcl.2018.11.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2018] [Revised: 11/04/2018] [Accepted: 11/08/2018] [Indexed: 11/25/2022]
Abstract
A HTS screen for CCR1 antagonists afforded a novel sub-micromolar hit 5 containing a pyrazole core. In this report the design, optimization, and SAR of novel CCR1 antagonists based on a pyrazole core motif is presented. Optimization led to the advanced candidate compounds (S)-16q and (S)-16r with 250-fold improved CCR1 potency, excellent off-target selectivity and attractive drug-like properties.
Collapse
Affiliation(s)
- Christian Harcken
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA.
| | - Christopher Sarko
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Can Mao
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - John Lord
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Brian Raudenbush
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Hossein Razavi
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Pingrong Liu
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Alan Swinamer
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Darren Disalvo
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Thomas Lee
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Siqi Lin
- Compound Profiling Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Alison Kukulka
- Compound Profiling Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Heather Grbic
- Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Mita Patel
- Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Monica Patel
- Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Kim Fletcher
- Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - David Joseph
- Drug Discovery Support Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Della White
- Immunology & Respiratory Disease Research Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Laura Amodeo
- Immunology & Respiratory Disease Research Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Karen Berg
- Immunology & Respiratory Disease Research Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - Maryanne Brown
- Immunology & Respiratory Disease Research Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| | - David S Thomson
- Medicinal Chemistry Department, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, PO Box 368, Ridgefield, CT 06877-0368, USA
| |
Collapse
|
3
|
Santella JB, Gardner DS, Duncia JV, Wu H, Dhar M, Cavallaro C, Tebben AJ, Carter PH, Barrish JC, Yarde M, Briceno SW, Cvijic ME, Grafstrom RR, Liu R, Patel SR, Watson AJ, Yang G, Rose AV, Vickery RD, Caceres-Cortes J, Caporuscio C, Camac DM, Khan JA, An Y, Foster WR, Davies P, Hynes J. Discovery of the CCR1 Antagonist, BMS-817399, for the Treatment of Rheumatoid Arthritis. J Med Chem 2014; 57:7550-64. [DOI: 10.1021/jm5003167] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Joseph B. Santella
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Daniel S. Gardner
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - John V. Duncia
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Hong Wu
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Murali Dhar
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Cullen Cavallaro
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Andrew J. Tebben
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Percy H. Carter
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Joel C. Barrish
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Melissa Yarde
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Stephanie W. Briceno
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Mary Ellen Cvijic
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - R. Robert Grafstrom
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Richard Liu
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Sima R. Patel
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Andrew J. Watson
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Guchen Yang
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Anne V. Rose
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Rodney D. Vickery
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Janet Caceres-Cortes
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Christian Caporuscio
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Daniel M. Camac
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Javed A. Khan
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Yongmi An
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - William R. Foster
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - Paul Davies
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| | - John Hynes
- Bristol Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
| |
Collapse
|
4
|
Chukwu JU, López C, González A, Font-Bardía M, Calvet MT, Messeguer R, Calvis C. Pd(II) complexes with N-substituted pyrazoles as ligands. The influence of the R group [OMe versus NMe2] of [1-{R–(CH2)2–}-3,5-Ph2–(C3HN2)] on their cytotoxic activity on breast cancer cell lines. J Organomet Chem 2014. [DOI: 10.1016/j.jorganchem.2014.04.034] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
|
5
|
Gardner DS, Santella JB, Duncia JV, Carter PH, Dhar T, Wu H, Guo W, Cavallaro C, Van Kirk K, Yarde M, Briceno SW, Robert Grafstrom R, Liu R, Patel SR, Tebben AJ, Camac D, Khan J, Watson A, Yang G, Rose A, Foster WR, Cvijic ME, Davies P, Hynes J. The discovery of BMS-457, a potent and selective CCR1 antagonist. Bioorg Med Chem Lett 2013; 23:3833-40. [DOI: 10.1016/j.bmcl.2013.04.079] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2013] [Revised: 04/24/2013] [Accepted: 04/29/2013] [Indexed: 02/07/2023]
|
6
|
Cavallaro CL, Briceno S, Chen J, Cvijic ME, Davies P, Hynes J, Liu RQ, Mandlekar S, Rose AV, Tebben AJ, Van Kirk K, Watson A, Wu H, Yang G, Carter PH. Discovery and Lead Optimization of a Novel Series of CC Chemokine Receptor 1 (CCR1)-Selective Piperidine Antagonists via Parallel Synthesis. J Med Chem 2012; 55:9643-53. [DOI: 10.1021/jm300896d] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Affiliation(s)
- Cullen L. Cavallaro
- Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton,
New Jersey 08540, United States
| | - Stephanie Briceno
- Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton,
New Jersey 08540, United States
| | - Jing Chen
- Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton,
New Jersey 08540, United States
| | - Mary Ellen Cvijic
- Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton,
New Jersey 08540, United States
| | - Paul Davies
- Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton,
New Jersey 08540, United States
| | - John Hynes
- Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton,
New Jersey 08540, United States
| | - Rui-Qin Liu
- Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton,
New Jersey 08540, United States
| | - Sandhya Mandlekar
- Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton,
New Jersey 08540, United States
| | - Anne V. Rose
- Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton,
New Jersey 08540, United States
| | - Andrew J. Tebben
- Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton,
New Jersey 08540, United States
| | - Katy Van Kirk
- Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton,
New Jersey 08540, United States
| | - Andrew Watson
- Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton,
New Jersey 08540, United States
| | - Hong Wu
- Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton,
New Jersey 08540, United States
| | - Guchen Yang
- Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton,
New Jersey 08540, United States
| | - Percy H. Carter
- Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton,
New Jersey 08540, United States
| |
Collapse
|